Penumbra, Inc. (PEN)
323.79
-1.39
(-0.43%)
USD |
NYSE |
Aug 24, 16:00
323.79
0.00 (0.00%)
After-Hours: 20:00
Penumbra Debt to Equity Ratio : 0.139 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.139 |
| March 31, 2026 | 0.1467 |
| December 31, 2025 | 0.1539 |
| September 30, 2025 | 0.1597 |
| June 30, 2025 | 0.1704 |
| March 31, 2025 | 0.1819 |
| December 31, 2024 | 0.1941 |
| September 30, 2024 | 0.2053 |
| June 30, 2024 | 0.197 |
| March 31, 2024 | 0.1923 |
| December 31, 2023 | 0.1988 |
| September 30, 2023 | 0.2072 |
| June 30, 2023 | 0.2168 |
| March 31, 2023 | 0.2279 |
| December 31, 2022 | 0.236 |
| September 30, 2022 | 0.2234 |
| June 30, 2022 | 0.2267 |
| March 31, 2022 | 0.2283 |
| December 31, 2021 | 0.1819 |
| September 30, 2021 | 0.252 |
| June 30, 2021 | 0.19 |
| March 31, 2021 | 0.1172 |
| December 31, 2020 | 0.1205 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.1257 |
| June 30, 2020 | 0.1242 |
| March 31, 2020 | 0.1632 |
| December 31, 2019 | 0.1694 |
| September 30, 2019 | 0.1058 |
| June 30, 2019 | 0.1099 |
| March 31, 2019 | 0.1139 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp. | 0.5064 |
| Globus Medical, Inc. | 0.0235 |
| Abbott Laboratories | 0.638 |
| AngioDynamics, Inc. | 0.0641 |
| Teleflex, Inc. | 0.989 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.975B |
| Total Liabilities (Quarterly) | 443.96M |
| Shareholders Equity (Quarterly) | 1.531B |
| Current Ratio | 5.750 |
| Net Debt Paydown Yield | 0.01% |